Caroline A. Nelson, MD; Lourdes Maria Pérez-Chada, MD, MMSc; Andrew Creadore, BS; et al.
free access
has audio
JAMA Dermatol. 2020;156(5):501-512. doi:10.1001/jamadermatol.2019.5014
This qualitative study examines how the use of artificial intelligence as a screening tool is perceived by patients receiving care in a dermatology clinic.
-
Podcast:
Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening
Jack C. O鈥橞rien, MD; Hugh Nymeyer, MD, PhD; Allison Green, MD; et al.
free access
has audio
JAMA Dermatol. 2020;156(5):513-520. doi:10.1001/jamadermatol.2020.0034
This cohort study investigates the disease course in patients with morphea treated with standard-of-care therapy using validated clinical outcome measures.
-
Podcast:
Changes in Disease Activity and Damage Over Time in Patients With Morphea
Megan Arthur, MD; Nicole M. Fett, MD, MSCE; Emile Latour, MS; et al.
free access
JAMA Dermatol. 2020;156(5):521-528. doi:10.1001/jamadermatol.2020.0035
This cohort study evaluates the use of mycophenolate mofetil and mycophenolic acid for the treatment of morphea.
Jung Min Bae, MD, PhD; Hyun Jeong Ju, MD; Ro Woo Lee, MD; et al.
free access
JAMA Dermatol. 2020;156(5):529-537. doi:10.1001/jamadermatol.2020.0218
This cohort study investigates the risks of skin cancer and premalignant skin lesions among patients with vitiligo undergoing narrowband UV-B phototherapy, based on the number of narrowband UV-B phototherapy sessions.
David G. Li, MD, MBA; Ashley B. Pournamdari, BS; Kristina J. Liu, MD, MHS; et al.
free access
JAMA Dermatol. 2020;156(5):538-544. doi:10.1001/jamadermatol.2020.0135
This cohort study examines the association of the implementation of an algorithm-based, decision-support tool with changes in referral rates and treatment of adult acne among primary care clinicians.
Claire Mignard, MD; Maud Maho-Vaillant, PhD; Marie-Laure Golinski, PhD; et al.
free access
JAMA Dermatol. 2020;156(5):545-552. doi:10.1001/jamadermatol.2020.0290
This post hoc analysis of a randomized clinical trial examines factors associated with short-term relapse in patients with pemphigus treated with rituximab.
Catherine M. Olsen, PhD; John F. Thompson, MD; Nirmala Pandeya, PhD; et al.
free access
JAMA Dermatol. 2020;156(5):553-560. doi:10.1001/jamadermatol.2020.0470
This cross-sectional study examines the incidence of melanoma in men vs women between differing geographic locations, ages, and anatomic sites.
Nick Thoreson, BS; Dustin H. Marks, BS; J. Klint Peebles, MD; et al.
free access
JAMA Dermatol. 2020;156(5):561-565. doi:10.1001/jamadermatol.2020.0480
This cross-sectional study examines coverage of permanent hair removal in transgender and gender-minority patients by marketplace and Medicaid health insurance policies and correlates the policies in each state with statewide protections of coverage for gender-affirming care.